Stereotactic core-needle biopsy of the breast: A report of the Joint Task Force of the American College of Radiology, American College of Surgeons, and College of American Pathologists

Ca-A Cancer Journal for Clinicians

Volumn 47, Issue 3, 1997, Pages 171-190

  Bassett, Lawrence ^a   Winchester, David P ^b   Caplan, Robert B ^c   David Dershaw, D David ^d   Dowlatshahi, Kambiz ^e   Evans III, W Phil ^f   Fajardo, Laurie L ^g   Fitzgibbons, Patrick L ^h   Henson, Donald E ⁱ   Hutter, Robert V P ^j   Morrow, Monica ^k   Paquelet, Jean R ^l   Eva Singletary, S ^m   Curry, John ⁿ   Wilcox Buchalla, Pam ⁿ   Zinninger, Marie ⁿ  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AMERICAN COLLEGE OF SURGEONS   (United States)

^c American Society of Breast Surgeons   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e St Lakes Medical Center   (United States)

^f BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^g UNIVERSITY OF VIRGINIA   (United States)

^h ST JUDE MEDICAL CENTER   (United States)

ⁱ NATIONAL CANCER INSTITUTE   (United States)

^j SAINT BARNABAS MEDICAL CENTER   (United States)

^k NORTHWESTERN UNIVERSITY   (United States)

^l GRANT MEDICAL CENTER   (United States)

^m UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

ⁿ AMERICAN COLLEGE OF RADIOLOGY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST DISEASE; BREAST EXAMINATION; COST EFFECTIVENESS ANALYSIS; DIFFERENTIAL DIAGNOSIS; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HEMATOMA; HISTOPATHOLOGY; HUMAN; IMAGING; INFECTION; INFORMED CONSENT; MAMMOGRAPHY; MEDICAL DECISION MAKING; MICROSCOPY; NEEDLE BIOPSY; PAIN; PATIENT CARE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RADIOGRAPHY; STEREOTAXIS; STORAGE; UTILIZATION REVIEW;

EID: 0030976322     PISSN: 00079235     EISSN: None     Source Type: Journal    
DOI: 10.3322/canjclin.47.3.171     Document Type: Article

References (84)

1. American College of Radiology: Breast Imaging Reporting and Data System (BI-RAOS), ed 2. Reston, Virginia, American College of Radiology, 1995
2. Cyrlak D: Induced costs of low-cost screening mammography. Radiology 1988;168:661-663.
3. Moskowitz M: Impact of a priori medical decisions on screening for breast cancer. Radiology 1989;171:605-608.
4. Bassett LW, Liu, T-H, Giuliano AE, et al: The prevalence of carcinoma in palpable vs impalpable, mammographically detected lesions. AJR Am J Roentgenol 1991;157:21-24.
5. Hall FM, Storella JM, Silverstone DZ, et al: Nonpalpable breast lesions: Recommendations for biopsy based on suspicion of carcinoma at mammography. Radiology 1988;167:353-358.
6. Brown ML, Houn F, Sickles EA. et al: Screening mammography in community practice: Positive predictive value of abnormal findings and yield of follow-up diagnostic procedures. AJR Am J Roentgenol 1995;165:1373-1377.
7. Howard J: Using mammography for cancer control: An unrealized potential. CA Cancer J Clin 1987;33:33-48.
8. Azavedo E, Svane G, Auer G: Stereotactic fine-needle biopsy in 2594 mammographically detected non-palpable lesions. Lancet 1989;1:1033-1036.
9. Kopans DB: Fine-needle aspiration of clinically occult breast lesions. Radiology 1989;170:313-314. Editorial.
10. Jackson VP, Bassett LW: Stereotactic fine-needle aspiration biopsy for nonpalpable breast lesions. AJR Am J Roentgenol 1990;154:1196-1197.
11. Masood S: Occult breast lesions and aspiration biopsy: A new challenge. Diagn Cytopathol 1993;4:613-614. Editorial.
12. Costa MJ, Tadros T, Hilton G, et al: Breast fine needle aspiration cytology: Utility as a screening tool for clinically palpable lesions. Acta Cytol 1993;37:461-471.
13. Parker SH, Lovin JD, Jobe WE, et al: Stereotactic breast biopsy with a biopsy gun. Radiology 1990;176:741-747.
14. McCombs MM, Bassett LW, Jahan R, et al: Imagina-guided core biopsy of the breast. Breast J 1996;1:9-16.
15. Liberman L, Dershaw DD, Rosen PP, et al: Stereotaxic core biopsy of breast carcinoma: Accuracy at predicting invasion. Radiology 1995;194:379-81.
16. Carty NJ, Ravichandran D, Carter C, et al: Randomized comparison of fine-needle aspiration cytology and Biopty-Cut needle biopsy after unsatisfactory initial cytology of discrete breast lesions. Br J Surg 1994;81:1313-1314.
17. Parker SH, Jobe WE, Dennis MA, et al: US-guided automated large-core breast biopsy. Radiology 1993;187:507-511
18. Dowlatshahi K, Yaremko ML, Kluskens LF, et al: Nonpalpable breast lesions: Findings of stereotaxic needle-core biopsy and fine-needle aspiration cytology. Radiology 1991;181:745-750.
19. Dronkers DJ: Stereotaxic core biopsy of breast lesions. Radiology 1992;183:63-634.
20. Elvecrog EL, Lechner MC, Nelson MJ: Nonpalpable breast lesions: Correlation of stereotaxic large-core-needle biopsy and surgical biopsy results. Radiology 1993;188:453-455.
21. Gisvold JJ, Goellner JR, Grant CS, et al: Breast biopsy: A comparative study of stereotaxically guided core and excisional techniques. AJR Am J Roentgenol 1994;162:815-820
22. Jackman RJ, Nowels KW, Shepard MJ. et al: Stereotaxic large-core-needle biopsy of 450 nonpalpable breast lesions with surgical correlations in lesions with cancer or atypical hyperplasia. Radiology 1994;193:91-95.
23. Mikhail RA, Nathan RC, Weiss M, et al: Stereotactic core-needle biopsy of mammographic breast lesions as a viable alternative to surgical biopsy. Ann Surg Oncol 1994;1:363-367.
24. Janes RH, Bouton MS: Initial 300 consecutive stereotactic core-needle breast biopsies by a surgical group. Am J Surg 1994;168:533-536.
25. Parker SH, Lovin JD, Johe WE, et al: Nonpalpable breast lesions: Stereotactic automated large-core biopsies. Radiology 1991;180:403-407.
26. Brenner RJ, Fajardo L, Fisher PR, et al: Percutaneous core biopsy of the breast: Effect of operator experience and number of samples on diagnostic accuracy AJR Am J Roentgenol 1996;166:341-346.
27. Doyle AJ, Murray KA, Nelson EW, et al: Selective use of image-guided large-core-needle biopsy of the breast: Accuracy and cost-effectiveness. AJR Am J Roentgenol 1995;165:281-284.
28. Israel PZ, Fine RE: Stereotactic needle biopsy for occult breast lesions: A minimally invasive alternative Am Surg 1995;61:87-91.
29. Meyer JE, Christian RL, Lester SC, et al: Evaluation of nonpalpable solid breast masses with stereotaxic large-needle core biopsy using a dedicated unit. AJR Am J Roentgenol 1996;167:179-182.
30. Nath ME, Robinson TM, Tobin H, et al: Automated large-core-needle biopsy of surgically removed breast lesions: Comparison of samples obtained with 14-, 16-. and 18-gauee needles Radiology 1995;197:739-742.
31. Liberman L, Dershaw DD, Rosen PP, et al: Stereotaxic 14-gauge breast biopsy: How many core biopsy specimens are needed? Radiology 1994;192:793-795.
32. Meyer JE, Lester SC, Frenna TH, et al: Occult breast calcifications sampled with large-core biopsy: Confirmation with radiography of the specimen. Radiology 1993;188:581-582.
33. Liberman L, Evans WP 3rd, Dershaw DD. et al: Radiography of microcalcifications in stereotaxic mammary core biopsy specimens. Radiology 1994;190:223-225.
34. Parker SH, Burbank F, Jackman RJ, et al: Percutaneous large-core breast biopsy: A multi-institutional study. Radiology 1994;193:359-364.
35. Norton LW, Zeligman BE, Pearlman NW: Accuracy and cost of needle localization breast biopsy Arch Surg 1988;123:947-950.
36. Morrow M: When can stereotactic core biopsy replace excisional biopsy? A clinical perspective. Breast Cancer Res Treat 1995;36:1-9.
37. Kopans DB: Caution on core. Radiology 1994;193:325-326.
38. Helvie MA, Pennes DR, Rebner M, et al: Mammographic follow-up of low-suspicion lesions: Compliance rate and diagnostic yield. Radiology 1991;178:155-158.
39. Harter LP, Curtis JS, Ponto G, et al: Malignant seeding of the needle track during stereotaxic core-needle breast biopsy. Radiology 1992;185:713-714.
40. Youngson BJ, Liberman L, Rosen PP: Displacement of carcinornatous epithelium in surgical breast specimens following stereotaxic core biopsy Am J Clin Pathol 1995;103:598-602.
41. Liberman L, Fahs MC, Dershaw DD, et al: Impact of stereotaxic core breast biopsy on cost of diagnosis. Radiology 1995;195:633-637.
42. Lindfors KK, Rosenquist CJ: Needle core biopsy guided with mammography: A study of cost-effectiveness. Radiology 1994;190:217-222.
43. Sickles EA, Parker SH: Appropriate role of core beast biopsy in the management of probably benign lesions. Radiology 1993;188:315. Editorial
44. Logan-Young WW, Janus JA, Destounis SV, et al: Appropriate role of core breast biopsy in the management of probably bengin lesions Radiology 1994;190:313-314.
45. Rubin E, Dempsey PJ, Pile NS, et al: Needle- localization biopsy of the breast. Impact of a selec- tive core-needle biopsy program on yield Radiology 1995;195:627-631.
46. Meyer JE: Value of large-core biopsy of occult breast lesions. AJR Am J Roentgenol 1992;158:991-992.
47. Parker SH: When is core biopsy really core? Radiology 1992;185:641-642. Comment.
48. Hopper KD, Baird DE, Reddy VV, et al: Efficacy of automated biopsy guns versus conventional biopsy needles in the pygmy pig. Radiology 1990;176:671-676.
49. Hann LE, Liberman L, Dershaw DD, et al: Mammography immediately after stereotaxic breast biopsy: Is it necessary? AJR Am J Roentgenol 1995;165:59-62.
50. Dershaw DD, Morris EA, Liberman L, et al: Nondiagnostic stereotaxic core breast biopsy: Results of rebiopsy. Radiology 1996;198:323-325.
51. Henson DE, Oberraan HA, Mutter RV: Practice protocol for the examination of specimens removed from patients with breast cancer. Arch Pathol Lab Med 1997;121:27-33.
52. Association of Directors of Anatomic and Surgical Pathology: Recommendations for the reporting of breast carcinoma. Mod Pathol 1996;9:77-81.
53. Association of Directors of Anatomic and Surgical Pathology: Immediate management of mammographically detected breast lesions. Hum Pathol 1993;24:689-690.
54. College of American Pathologist: Guideline for data to be included in consultation reports on breast cancer, bladder cancer, and Hodgkins disease. Pathologist 1986;40:18-23.
55. Schmidt RA: Stereotactic breast biopsy. CA Cancer J Clin 1994;44:172-191.
56. Lagios MD, Bennington JL: Protocol for the pathologic examination and tissue processing of the mammographically directed breast biopsy, in Bennington JL, Lagios MD (eds): The Mammographically Directed Biopsy, vol 1. Philadelphia, Hanley & Belfus, 1992, pp 23-45.
57. Schnitt SJ, Connolly JL: Processing and evaluation of breast excision specimens: A clinically oriented approach. Am J Clin Pathol 1992;98:125-137.
58. Holland R, Hendriks JH: Microcalcifications associated with ductal carcinoma in situ: Mammographic-pathologic correlation. Semin Diagn Pathol 1994;11:181-192.
59. Fechner RE: Frozen section examination of breast biopsies. Practice parameter. Am J Clin Pathol 1995;103:6-7.
60. Battifora H, Mehta P, Ahn C, et al: Estrogen receptor immunohistochemical assay in paraffin-embedded tissue. A better gold standard? Appl Immunohistochem 1993;1:39-45.
61. Battifora H: Immyoncytochemistry of hormone receptors in routinely processed tissues. The new gold standard. Appl Immunohistochem 1994;2:143-145
62. Graham DM, Jin L, Lloyd RV: Detection of estrogen receptor in paraffin-embedded sections of breast carcinoma by immunohistochemistry and in situ hybridization Am J Surg Pathol 1991;15:475-485.
63. Esteban JM, Battifora H, Warsi Z, et al: Quantification of estrogen receptors on paraifin-embedded tumors by, image analysis. Mod Pathol 1991;4:53-57.
64. Brenner RJ, Bassett LW, Dershaw DD, et al: Percutaneous core biopsy of the breast A multisite prospective trial. Radiology 1994:193(Suppl):295. Abstract.
65. Linell F: Precursors lesions of breast carcinoma. Breast 1993;2:202-223.
66. Petrek JA: Cystosarcoma phyllodes in Harris JR. Hellman S. Henderson IC. et al (eds): Breast Diseases, ed 2 Philadelphia. JB Lipincott. 1991. pp791-797.
67. Is "fibrocystic disease" of the breast precancerous? Arch Pathol Lab Med 1986;110:171-173.
68. Kamel OW, Kempson RL, Hendrickson MR: In situ proliferative epithelial lesions of the breast, in Bennington JL. Lagios MD (eds): The Mammographically. Hanley & Belfus, 1992, p.65.
69. Morrow M: Identification and management of the woman at increased risk for breast cancer development. Breast Cancer Res Treat 1994;31:53-60.
70. Holland R, Veling S, Mravunac M, et al: Histologic multifocality of Tis, T1-2 breast carcinomas: Implications for clinical trials of breast-conserving treatment. Cancer 1985;56:979-990.
71. Holland R, Connolly J, Gelman R, et al: The presence of an extensive intraductal component following a limited excision correlates with prominent residual diseases in the remainder of the breast. J Clin Oncol 1990;8:113-118.
72. Holland R, Hendricks J, Verbeek A, et al: Extent distribution, and mammographic/histogical Lancet 1990;335:519-522.
73. Head JF, Bruce TL, Haynes AE, et al: Two year follow-up of a prospective study of patients with abnormal mammograms who had stereotaxic localization and needle biopsy of non-palable breast lesions. Proc Am Soc Clin Oncol 1993;12:56. Abstract.
74. Jackman RJ, Finklestein SI, Marzoni FA Jr: Stereotaxic large-core-needle biopsy of histologically bemigen nonpalpable breast lesions: False-negative results and failed follow-up. Radiology 1995;197(Suppl):203.Abstract.
75. Pal S, Ikeda DM, Birdwel RL: Retrospective study of compliance with recomended follow-up. Radiology 1995;197(Suppl):407. Abstract.
76. Lerman C, Rimer B, Trock B, et al: Factors associated with repeat adherence to breast cancer screening. Prev Med 1990;19:279-290.
77. Sickles EA: Quality assurance: How to audit your own mammography practice. Radiol Clin North Am 1992;30:265-275.
78. Linver MN, Osuch JR, Brenner RJ, et al: The mammography audit: A primer for the mammagrophy quality standards act (MQSA). AJR Am J Roentgenol 1995;165:19-25.
79. Sickles EA, Parker SH: Appropriate role of core breast biopsy in the management of probably lesions. Radiology 1993;188:315. Editorial.
80. Hall FM, Strollea JM, Silverstone DZ, et al: Nonpalpable breast lesions: Recommendations for biopsy based on suspicion of carcinoma at mammography. Radiology 1988;167:353-358.
81. Moseson D: Audit of mammography in a community setting. Am J Surg 1992;163:544-546.
82. Rubin E, Dempsey PJ, Pile NS, et al: Needle-localization biopsy of the breast: Impact of a selective core-needle biopsy program on yeild. Radiology 1995;195:627-631.
83. Lindfords KK, Rosequnist CJ: Needle core biopsy guided with mammography: A study of cost-effectiveness. Radiology 1994;190:217-222.
84. Sickles EA: Periodic mammographic follow-up of probably benign lesions: Results in 3,184 consecutive cases Radiology 1991;179:463-468.